A Wayne County, Michigan, couple has filed a life-threatening bleeding lawsuit, alleging that the widely popular blood-thinner caused the wife to suffer severe internal bleeding. Plaintiffs F. and J. Felicia Anderson have joined thousands of other users who accuse the drug’s makers, Johnson & Johnson and Bayer, of knowing the risks of internal bleeding while […]
Lawsuit: Life-Threatening Bleeding Risk Was Hidden Read More »
Bayer HealthCare, the makers of blood thinning drug , was recently told a bellwether trial would move forward after Bayer requested a summary judgment. This bellwether trial, citing mainly Bayer’s failure to warn about severe bleeding injuries, is the third bellwether trial to be heard in this massive multidistrict litigation. A bellwether trial is essentially
Bellwether Trial Moves Forward Despite Objections Read More »
The blood thinner (rivaroxaban) is not only inferior to the decades-old Coumadin (warfarin), is “the worst” of all the new generation oral anticoagulants on the market, an expert cardiologist testified during the second bellwether trial. Dr. Frank Smart, the chief of cardiology and a professor of medicine at Louisiana State University School of Medicine, told
Expert: Blood Thinner ‘the Worst’ Anticoagulant Read More »
A New York man has filed a lawsuit against Janssen Research & Development LLC, Bayer Healthcare Pharmaceuticals and related entities alleging he suffered uncontrolled bleeding. According to the bleeding lawsuit, plaintiff Robert S. used the oral anticoagulant from approximately June 21, 2013 through September 2013. Robert says he coughed up blood on Aug. 22, 2013
Bleeding Lawsuit: Blood Thinner Caused Uncontrollable Bleeding Read More »
A Louisiana man who says he suffered “a life-threatening, irreversible bleed” caused by the blood thinner has filed a products liability lawsuit against pharmaceutical giants, Janssen and Bayer. Wilburn D. of Vernon Parrish, Louisiana, who was prescribed (rivaroxaban) in February 2015 to treat atrial fibrillation, joins some 16,000 other plaintiffs in a federal multi-district litigation,
Lawsuit Alleges Drug Caused Internal Bleeding Read More »
The widely popular blood-thinner —generically known as rivaroxaban—is FDA-approved to reduce the risk of blood clots, deep vein thrombosis and pulmonary embolism in knee and hip replacement surgery patients and to reduce the risk of stroke and blood clots in patients with an abnormal heart rhythm, a condition known as non-valvular atrial fibrillation. By decreasing
More Than 18,000 Suing Over Bleeding Side Effect Read More »
The makers of the , a drug used to reduce the risk of stroke in hip and knee replacement patients, were hit with a lawsuit alleging the drug caused unintended major bleeding. Plaintiff Isabel L. alleges in her lawsuit that she was prescribed in October of 2013. According to Isabel, several days later she was
Lawsuit Says Drug Causes Major Bleeding Read More »